Intravenous Thrombolysis in Patients With Ischemic Stroke Aged ≥90 Years: A Cohort Study From the TRISP Collaboration.

Publication

Intravenous Thrombolysis in Patients With Ischemic Stroke Aged ≥90 Years: A Cohort Study From the TRISP Collaboration.

Journal Paper/Review - Oct 14, 2022

Altersberger Valerian L, Rusche Norman, Martinez-Majander Nicolas, Hametner Christian, Scheitz Jan F, Hénon Hilde, Dell'Acqua Maria Luisa, Strambo Davide, Stolp Jeffrey, Heldner Mirjam R, Grisendi Ilaria, Jovanovic Dejana R, Béjot Yannick, Pezzini Alessandro, Leker Ronen R, Kägi Georg, Wegener Susanne, Cereda Carlo Walter, Lindgren Erik, Ntaios Georges, Piot Ines, Polymeris Alexandros A, Lyrer Philippe A, Räty Silja, Sibolt Gerli, Tiainen Marjaana, Heyse Miriam, Erdur Hebun, Kaaouana Olfa, Padjen Visnja, Zedde Marialuisa, Arnold Marcel, Nederkoorn Paul J J, Michel Patrik, Bigliardi Guido, Zini Andrea, Cordonnier Charlotte, Nolte Christian H, Ringleb Peter Arthur, Curtze Sami, Engelter Stefan T, Gensicke Henrik, Thrombolysis in Stroke Patients (TRISP) Collaborators

Citation

Altersberger V, Rusche N, Martinez-Majander N, Hametner C, Scheitz J, Hénon H, Dell'Acqua M, Strambo D, Stolp J, Heldner M, Grisendi I, Jovanovic D, Béjot Y, Pezzini A, Leker R, Kägi G, Wegener S, Cereda C, Lindgren E, Ntaios G, Piot I, Polymeris A, Lyrer P, Räty S, Sibolt G, Tiainen M, Heyse M, Erdur H, Kaaouana O, Padjen V, Zedde M, Arnold M, Nederkoorn P, Michel P, Bigliardi G, Zini A, Cordonnier C, Nolte C, Ringleb P, Curtze S, Engelter S, Gensicke H, Thrombolysis in Stroke Patients (TRISP) Collaborators. Intravenous Thrombolysis in Patients With Ischemic Stroke Aged ≥90 Years: A Cohort Study From the TRISP Collaboration. Stroke 2022; 53:3557-3563.

Type

Journal Paper/Review (English)

Journal

Stroke 2022; 53

Publication Date

Oct 14, 2022

Issn Electronic

1524-4628

Pages

3557-3563

Brief description/objective

The probability to receive intravenous thrombolysis (IVT) for treatment of acute ischemic stroke declines with increasing age and is consequently the lowest in very elderly patients. Safety concerns likely influence individual IVT treatment decisions. Using data from a large IVT registry, we aimed to provide more evidence on safety of IVT in the very elderly.